Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Let’s be frank
View:
Post by Bucknelly21 on Apr 19, 2021 2:16pm

Let’s be frank

At this point the value is only going to come from positive results, they don't have the capability to promote the story they have created. But from some reason they believe they do and continue the same old strategy. Their interest in not aligned with our own. Like many have said. I believe there are some highly capable people there but seem to have little impact on the day to day promotion of the company. That's because the orders from the top are the same ol boring mindless strategies they have tried for ever
Comment by qwerty22 on Apr 19, 2021 3:23pm
All I eff'ing care about now is seeing the fabled NASH protocol so we can understand exactly what that program is and seeing some cancer human data, that's all that really matters in 2021 for THTX. I'll support sending Wino in to beat that out of Paul!  
Comment by juniper88 on Apr 19, 2021 3:42pm
I believe fundementally that is what most of us here care about and that is why we are invested.  But lack of proper analysts following this company, and/or enought retail investors know about the company the stock price will not appreciate to its proper potential with good results.  Just look at history.  The OO happened because there were never enough eyes on this company.
Comment by SPCEO1 on Apr 19, 2021 4:28pm
Well said. I would like to also point out that shareholders have been exrtaordinarily patient over the years hoping the management team could get this problem fixed. Instead, it has only gotten worse - actually a lot worse. So, that we are asking that something be done to fix this most basic aspect of running a public company should not be a shocking or unusual development. It is years overdue and ...more  
Comment by JayjayUSA12007 on Apr 19, 2021 5:04pm
Quote:"The total disengagement of the analysts on the last conference call was the final straw as it exposed beyond a shadow of a doubt that the problem is a substantial one." Exactly, the lack of analysts at the conference call tells us: 1/ Thera doesn't care about the investment community, and by extension, its shareholders. 2/ If it caught them off-guard, itt's obviously an ...more  
Comment by houbahop on Apr 19, 2021 5:10pm
Hopefully, all the energy you have spent up to now to make the company a better one, will receive consideration by the BOD. You have all my words of encouragements. The difficulty resides in changing the attitude of the Directors towards their shareholders. Is this possible without changing the directors themselves? How are these directors willing to assume their fiduciary duties? Is it a ...more  
Comment by qwerty22 on Apr 19, 2021 5:46pm
Cancer has exceeded expectation in execution of preclinical and IND, fast track is the result, messaging is crystal clear. It's all great just needs hard human data to realize it's potential.    They've admitted the need for a reset on sales. Paul has the CV to execute. The messaging is clear. Just needs to execute on the numbers. It all falls down on NASH. The ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities